Active Ingredient: KETOCONAZOLE
Proprietary Name: EXTINA
Dosage Form; Route of Administration: AEROSOL, FOAM; TOPICAL
Strength: 2%
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021738
Product Number: 001
Approval Date: Jun 12, 2007
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information